252 related articles for article (PubMed ID: 6610253)
1. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections.
Ellison RT; Judson FN; Peterson LC; Cohn DL; Ehret JM
West J Med; 1984 May; 140(5):735-40. PubMed ID: 6610253
[TBL] [Abstract][Full Text] [Related]
2. Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.
Peterson LR; Quick JN; Jensen B; Homann S; Johnson S; Tenquist J; Shanholtzer C; Petzel RA; Sinn L; Gerding DN
Arch Intern Med; 1990 Oct; 150(10):2151-5. PubMed ID: 2222100
[TBL] [Abstract][Full Text] [Related]
3. Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin.
Roccaforte JS; Bittner MJ; Stumpf CA; Preheim LC
Am J Infect Control; 1988 Aug; 16(4):141-6. PubMed ID: 3263821
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
5. Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak.
Bacon AE; Jorgensen KA; Wilson KH; Kauffman CA
Infect Control; 1987 Apr; 8(4):145-50. PubMed ID: 3495516
[TBL] [Abstract][Full Text] [Related]
6. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Arnold FW; Wojda B
J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
Al-Shawwa BA; Wegner D
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
[TBL] [Abstract][Full Text] [Related]
8. Failure of rifampin to eradicate methicillin-resistant Staphylococcus aureus colonization.
Canawati HN; Tuddenham WJ; Sapico FL; Montgomerie JZ; Aeilts GD
Clin Ther; 1982; 4(6):526-31. PubMed ID: 6920285
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
Safdar N; Marx J; Meyer NA; Maki DG
Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
[TBL] [Abstract][Full Text] [Related]
10. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
Phillips S; MacDougall C; Holdford DA
Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
[TBL] [Abstract][Full Text] [Related]
11. [Clinical epidemiology of an outbreak of nosocomial infection caused by Staphylococcus aureus resistant to methicillin and aminoglycosides: efficacy of control measures. Comité de Control de Infecciones].
Trilla A; Marco F; Moreno A; Prat A; Soriano E; Jiménez de Anta MT
Med Clin (Barc); 1993 Feb; 100(6):205-9. PubMed ID: 8429724
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
Garske LA; Kidd TJ; Gan R; Bunting JP; Franks CA; Coulter C; Masel PJ; Bell SC
J Hosp Infect; 2004 Mar; 56(3):208-14. PubMed ID: 15003669
[TBL] [Abstract][Full Text] [Related]
13. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of infectious endocarditis with trimethoprim-sulfamethoxazole and cardiac surgery].
Tokatli A; Topçu M; Ozkutlu S; Akçevim A
Mikrobiyol Bul; 1986 Jul; 20(3):196-9. PubMed ID: 3494182
[TBL] [Abstract][Full Text] [Related]
15. Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen.
Martin MA
Curr Clin Top Infect Dis; 1994; 14():170-91. PubMed ID: 8086114
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus transmission: the possible importance of unrecognized health care worker carriage.
Ben-David D; Mermel LA; Parenteau S
Am J Infect Control; 2008 Mar; 36(2):93-7. PubMed ID: 18313510
[TBL] [Abstract][Full Text] [Related]
17. Treatment of salmonella carriers with trimethoprim-sulfamethoxazole.
Clementi KJ
Can Med Assoc J; 1975 Jun; 112(13 Spec No):28-32. PubMed ID: 1093650
[TBL] [Abstract][Full Text] [Related]
18. An outbreak of methicillin-resistant Staphylococcus aureus infection in patients of a pediatric intensive care unit and high carriage rate among health care workers.
Lin YC; Lauderdale TL; Lin HM; Chen PC; Cheng MF; Hsieh KS; Liu YC
J Microbiol Immunol Infect; 2007 Aug; 40(4):325-34. PubMed ID: 17712467
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
20. Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Australian Group on Antimicrobial Resistance (AGAR).
Turnidge JD; Nimmo GR; Francis G
Med J Aust; 1996 Jan; 164(2):68-71. PubMed ID: 8569574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
